IP Library Granted Patent US 8,895,787
Granted Patent B2
US 8,895,787 · App. 13/450,233 · Granted Nov 25, 2014

Compositions comprising a dehalogenase substrate and a radionuclide and methods of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,895,787
App. No.
13/450,233
Granted
Nov 25, 2014
Kind
B2
Abstract

A mutant hydrolase optionally fused to a protein of interest is provided. The mutant hydrolase is capable of forming a bond with a substrate for the corresponding nonmutant (wild-type) hydrolase which is more stable than the bond formed between the wild-type hydrolase and the substrate. Substrates for hydrolases comprising one or more functional groups are also provided, as well as methods of using the mutant hydrolase and the substrates of the invention. Also provided is a fusion protein capable of forming a stable bond with a substrate and cells which express the fusion protein.

Claims (18)

1. A complex of a radionuclide and a compound of formula (I): R-linker-A-X, wherein R comprises a metal ion chelator, wherein the linker is a multiatom straight or branched chain including C, N, S and/or O and comprising no more than 30 carbon atoms, wherein A-X is a substrate for a dehalogenase, wherein A is (CH 2 ) n and n=2-10, and wherein X is a halogen.

2. The complex of claim 1 , which is a substrate for a Rhodococcus dehalogenase.

3. The complex of claim 1 , wherein X is Cl or Br.

4. The complex of claim 1 , wherein the linker separates R and A by at least 11 atoms.

5. The complex of claim 1 , wherein the radionuclide is separated from A-X by up to 500 angstroms.

6. The complex of claim 1 , wherein the linker comprises —C(O)NH(CH 2 CH 2 O) y , wherein y=2-8.

7. A method to label a cell, comprising:

(a) contacting a cell comprising a mutant dehalogenase with the complex of claim 1 , wherein the mutant dehalogenase comprises at least one amino acid substitution relative to the corresponding wild-type dehalogenase, wherein the at least one amino acid substitution results in the mutant dehalogenase forming a bond with the substrate which is more stable than the bond formed between the corresponding wild-type dehalogenase and the substrate, wherein the at least one amino acid substitution in the mutant dehalogenase is a substitution (i) at an amino acid residue in the corresponding wild-type dehalogenase that is associated with activating a water molecule which cleaves the bond formed between the corresponding wild-type dehalogenase and the substrate or (ii) at an amino acid residue in the corresponding wild-type dehalogenase that forms an ester intermediate with the substrate; and

(b) incubating the cell with the complex, wherein the incubation results in the cell being labeled with the radionuclide in the complex.

8. The method of claim 7 , wherein the substrate is a substrate for a Rhodococcus dehalogenase.

9. The method of claim 7 , wherein X is Cl or Br.

10. The method of claim 7 , wherein the linker comprises —C(O)NH(CH 2 CH 2 O) y , wherein y=2-8.

11. A method to detect or determine the presence or amount of a mutant dehalogenase, comprising:

a) contacting a mutant dehalogenase with the complex of claim 1 , wherein the mutant dehalogenase comprises at least one amino acid substitution relative to the corresponding wild-type dehalogenase, wherein the at least one amino acid substitution results in the mutant dehalogenase forming a bond with the substrate which is more stable than the bond formed between the corresponding wild-type dehalogenase and the substrate, wherein the at least one amino acid substitution in the mutant dehalogenase is a substitution (i) at an amino acid residue in the corresponding wild-type dehalogenase that is associated with activating a water molecule which cleaves the bond formed between the corresponding wild-type dehalogenase and the substrate or (ii) at an amino acid residue in the corresponding wild-type dehalogenase that forms an ester intermediate with the substrate; and

b) detecting or determining the presence or amount of the radionuclide, thereby detecting or determining the presence or amount of the mutant dehalogenase.

12. The method of claim 11 , wherein the substrate is a substrate for a Rhodococcus dehalogenase.

13. The method of claim 11 , wherein X is Cl or Br.

14. The method of claim 11 , wherein the linker comprises —C(O)NH(CH 2 CH 2 O) y , wherein y=2-8.

Assignments (2)
SECURITY INTEREST Recorded Apr 3, 2019
From: PROMEGA CORPORATION; PROMEGA BIOSCIENCES, LLC; TERSO SOLUTIONS, INC.; ORION SEVEN, LLC; PROMEGA AVIATION LLC
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 048790/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2012
From: WOOD, KEITH V.; LOS, GEORGYI V.; BULLEIT, ROBERT F.; ZIMPRICH, CHAD; KLAUBERT, DIETER; MCDOUGALL, MARK
To: PROMEGA CORPORATION
Reel/Frame 028258/0707 →